Viewing Study NCT01955668

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:28 PM
Ignite Modification Date: 2026-02-08 @ 1:28 PM
Study NCT ID: NCT01955668
Status: COMPLETED
Last Update Posted: 2014-06-19
First Post: 2013-09-30
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: AZD6738 First Time in Patient Multiple Ascending Dose Study
Sponsor: AstraZeneca
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None 11q-deleted Relapsed/Refractory Chronic Lymphocytic Leukaemia (CLL), View
None Prolymphocytic Leukaemia (PLL) View
None B Cell Lymphomas View
Keywords:

Keywords

Keyword Brief Keyword Text View
None 11q-deleted relapsed/refractory chronic lymphocytic leukaemia View
None Prolymphocytic leukaemia View
None B cell lymphomas View